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Evaluating the Case Against Pet Cloning
Abstract
The cause that opponents of pet cloning support is indisputably a worthy one: namely, the protection of
animal welfare. And because this type of animal cloning appears, at least at first glance, to have no noble
ends, the public and most animal ethicists have been content to let the cause, rather than the arguments,
carry the day. There is an overwhelmingly negative view of companion animal cloning among the lay
public, animal advocacy organizations, and professional ethicists. But how sound are their arguments
against pet cloning? Can they withstand careful scrutiny?
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The process of developing and managing
an effective internal controls program can be
challenging and expensive. In assessing the
value of such an investment, however, corporate
management needs to consider a number of
related factors:
1) The cost of internal investigations of
alleged violations can easily exceed
any potential monetary fines,
sometimes by several orders of
magnitude;
2) The tort exposure from the failure to
identify a problem customer (e.g.,
one with terrorist connections that
appears on a published government
list) could be almost unlimited; and
3) The reputational risk associated
with any alleged violation could be
significant; these regulations are
maintained to protect U.S. national
security and they are increasingly
seen as a major tool in its war
against terrorism.
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Review all business operating processes
and procedures for involvement of U.S.
persons in transactions involving
embargoed destinations.

Bill Clements is a Partner in the Washington,
DC office of Foley & Lardner LLP.
He
specializes in compliance issues related to U.S.
international trade controls and the Foreign
Corrupt Practices Act. He agreed to write this
article as a follow-up to a presentation he made
at the Biotechnology Committee's annual
meeting in Chicago in August 2005.
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Ensure subsidiaries in Canada, the EU,
and Mexico have mechanisms in place to
address local blocking statutes.

The cause that opponents of pet cloning
support is indisputably a worthy one: namely,
the protection of animal welfare. And because
this type of animal cloning appears, at least at
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first glance, to have no noble ends,1 the public
and most animal ethicists have been content to
let the cause, rather than the arguments, carry
the day. There is an overwhelmingly negative
view of companion animal cloning among the lay
public, animal advocacy organizations, and
professional ethicists. But how sound are their
arguments against pet cloning?
Can they
withstand careful scrutiny?

homes."3 Bioethicists agree. David Magnus,
Director of the Stanford Center for Biomedical
Ethics, argues, "The idea that somebody would
spend $50,000 for a cat when they can go to any
shelter and rescue one is absurd."4
What these arguments certainly get
right is the staggering problem of unwanted
animals in the United States. The National
Council on Pet Population Study and Policy
found that in 1997 alone, 2,329,978 dogs and
1,759,743 cats entered shelters, and between 5070% of these animals were euthanized.5 By
ASPCA estimates, 8-12 millions companion
animals enter shelters, and 60-70% are
euthanized.6 A similar number is cited in the
2001 Humane Society report on the state of
animals in the US. According to that report, 4-6
million dogs and cats were euthanized in
shelters in 2001.7 These figures do not include
the millions of stray animals in the country: the
ASPCA estimates that 70 million stray dogs and
cats live in the US.8

There are three ethical objections given
by pet cloning opponents: 1) the plight of
unwanted animals; 2) the exploitation of
grieving clients; and 3) the suffering of the
animals involved in the cloning process (the
donors, the surrogates, and the clones). An
analysis of the various arguments given by
opponents of pet cloning shows, however, that
only one argument can survive critical reflection,
and that argument – the concern about the
suffering of the actual clones – is the issue on
which the moral justification of pet cloning
hinges and around which the moral debate
ought to be focused.

The connection between the pet
overpopulation problem and pet cloning seems
obvious: there are many wonderful pets ready to
adopt, and adopting instead of cloning saves one
animal from euthanasia; therefore, one ought to
adopt rather than clone. When we add to that
argument the fact that each cat clone currently
costs $30,000, which – if redistributed – could
save thousands of animal lives, we appear to
come to the conclusion that the money ought to
be donated to shelters rather than devoted to the
purchase of just one animal. But there is a
serious problem with this argument against
companion animal cloning. If we interpret the

Let's start with the plight of unwanted
animals. The US pet overpopulation problem
has been cited repeatedly as a central objection
to companion animal cloning. For example, the
animal advocacy organization American AntiVivisection Society writes, "While pet cloning
firms currently are charging customers up to
$50,000 for a cloned cat and as much as $2,995
to 'bank' a dog's or cat's DNA for future cloning,
millions of homeless animals of the same species
are available in US shelters for a round $100,
which is used to cover costs. However, most
animals in shelters are euthanized for lack of
adopting homes."2
Says Humane Society
President Wayne Pacelle, "The Humane Society
of the United States opposes pet cloning because
it is dangerous for the animals involved, it serves
no compelling social purpose, and it threatens to
add to the pet overpopulation problem. It
doesn't sit well with us to create animals through
such extreme and experimental means when
there are so many animals desperate for
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above argument as the claim, "There are too
many cats in the world, therefore we shouldn't
be cloning more," then the flaw in the argument
might be called the "Hangnail vs. Hemorrhage"
problem. In terms of cat "production," cloning
represents a tiny hangnail, while we're currently
hemorrhaging to death from intentional and
unintentional breeding.
According to the
Humane Society of United States, there are
currently 77 million cats owned in US
households, and only 11.5 million were adopted
from shelters. 1 In other words, 66 million cats
were either purchased from breeders or bred by
owners (again, either because they wanted to
breed their cats, or because they didn't spay or
neuter them). To date: there have been 6 cats
cloned. If there are too many cats in the world,
and the quantity needs to be reduced to cure the
unwanted animal problem, then we should focus
on breeders and owners who don't spay. After
we have made a significant impact on the main
source of the problem, then we can focus on the
trivial contributors to the companion animal
numbers.

substitution."2 But this is not true. For pet
owners, cloning a pet is an expression of
profound grief and loss of intrinsically valuable
entity; therefore, having the identical twin of
beloved animal is closest they can come to
having some part of that animal "live on." There
is nothing irrational about this.
That leaves opponents with only one
remaining objection: the suffering of animals
involved in the process. But there are problems
here as well. Opponents cite three groups of
animals that suffer in the process of pet cloning:
the donors, the surrogates, and the clones. But
the only firm cloning pets to date uses eggs
procured from spay clinics, so there is no
suffering of the donors – their owners had their
ovaries removed to prevent future pregnancies
(a cause pet cloning opponents fully embrace),
so no procedure was performed on these animals
for the enterprise of pet cloning. As for the
surrogates, again in current practice, they are
adopted after one pregnancy, so their suffering is
equivalent to what a human woman goes
through in a successful cycle of in vitro, but then
they are adopted into homes. This turns out to
be, then, the equivalent of feline kidney
transplant, to which no one seems to raise
objections.

One additional irony of this argument
against companion animal cloning is that the
only firm currently cloning cats commercially
buys its donor eggs in the form of ovaries that
have been procured at spay clinics. The money
that those spay clinics receive for the ovaries is
used to spay other cats. So, at least while pet
cloning production remains extremely low, a pet
cloning firm that indirectly supports the spaying
of cats from this method of egg procurement
reduces the future pet population

That leaves the health status of the
clones, and here the opponents raise a serious
moral issue. The public does not have access to
the data about the number of stillbirths and
early neonatal losses in this process, and there
certainly are no long-term data on the health
status and long-term outcomes for the actual
clones. Here is where the opponents should
focus their energy in making sure that these
legitimate animal welfare concerns are
addressed.

The second objection to pet cloning
fares no better, namely, the exploitation of
grieving clients. On this argument, opponents
argue that buying a clone necessarily means
being deceived because without deceived clients
there wouldn't be clients. The idea here is that it
is irrational to want to have a later-born genetic
twin of a beloved pet, and if a client had an
accurate understanding of what cloning was, he
or she wouldn't want one.
For example,
Lawrence Hinman, Director of the Values
Institute, University of San Diego, argues, "We
can produce a genetically identical copy of our
pet, but we delude ourselves if we think we have
somehow accomplished something by the

Dr. Fiester is a senior fellow at the University of
Pennsylvania Center for Bioethics.
She
specializes in the ethics of animal cloning. She
agreed to write this essay for the Biotechnology
Committee as follow-up to the presentation she
gave at a program on pet cloning sponsored by
the Section of Science & Technology at the
annual meeting in August 2005.
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